×
About 9,723 results

ALLMedicine™ Urticaria Center

Research & Reviews  2,328 results

Simplifying the drug provocation test in non-immediate hypersensitivity reactions to am...
https://doi.org/10.1111/pai.13809
Pediatric Allergy and Immunology : Official Publication O... Liccioli G, Giovannini M et. al.

Jun 28th, 2022 - Mild non-immediate reactions (NIR) to beta-lactams (βLs) are the most common manifestation of adverse drug reactions in children, and the drug provocation test (DPT) remains the gold standard for diagnosis. However, there are still controversies a...

Risk Stratification through Allergy History: Single-centre Experience of Specialised CO...
https://doi.org/10.1093/cei/uxac064
Clinical and Experimental Immunology; Lyons D, Murray C et. al.

Jun 27th, 2022 - Anaphylaxis is a rare side-effect of Covid-19 vaccines. In order to (a) provide direct advice and reassurance to certain persons with a history of anaphylaxis/complex allergy, in addition to that available in national guidelines, and (b) to provid...

Pathogenesis of Physical Induced Urticarial Syndromes
https://clinicaltrials.gov/ct2/show/NCT00887939

Jun 24th, 2022 - Urticaria is a common skin disorder that is classified according to its chronicity into acute and chronic forms. It may occur spontaneously or on exposure to a physical factor. In the latter case, the urticaria is classified as a physical urticari...

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
https://clinicaltrials.gov/ct2/show/NCT03770273

Jun 24th, 2022 - Systemic mastocytosis is a disorder caused by clonal mast cell proliferation and release of mast cell mediators including tryptase. As a result, mast cell numbers may increase and affect target organs including the dermis (maculopapular cutaneous ...

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine
https://clinicaltrials.gov/ct2/show/NCT05107115

Jun 24th, 2022 - The first phase of this study will be a parallel, 12-week treatment, Phase 2, double-blind, 4 arm study to assess the safety and effectiveness of 3 oral doses of SAR444671 (rilzabrutinib), i.e. dose A, B and C, compared with placebo for decreasing...

see more →

Guidelines  7 results

The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and Why
https://pubmed.ncbi.nlm.nih.gov/33857657/
The Journal of Allergy and Clinical Immunology; Metz M

Jun 3rd, 2021 - In chronic spontaneous urticaria (CSU), the guidelines recommend very limited diagnostic procedures during the routine workup, although additional investigations might be indicated in some patients with CSU. For physicians treating patients with C...

Considerations on biologicals for patients with allergic disease in times of the COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and ma...
https://doi.org/10.1111/all.13397
Allergy Zuberbier T, Aberer W et. al.

Jan 18th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/...
https://doi.org/10.1111/all.12370
Allergy Zuberbier T, Aberer W et. al.

Jun 6th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...

Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German ...
https://doi.org/10.1111/j.1524-4725.2010.01495.x
Dermatologic Surgery : Official Publication for American ... Rabe E, Pannier F

Jul 16th, 2010 - Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. To update guidelines for sclerotherapy of varicose veins. The guidelines for sclerotherapy of varicose...

see more →

Drugs  921 results see all →

Clinicaltrials.gov  240 results

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
https://clinicaltrials.gov/ct2/show/NCT03770273

Jun 24th, 2022 - Systemic mastocytosis is a disorder caused by clonal mast cell proliferation and release of mast cell mediators including tryptase. As a result, mast cell numbers may increase and affect target organs including the dermis (maculopapular cutaneous ...

Pathogenesis of Physical Induced Urticarial Syndromes
https://clinicaltrials.gov/ct2/show/NCT00887939

Jun 24th, 2022 - Urticaria is a common skin disorder that is classified according to its chronicity into acute and chronic forms. It may occur spontaneously or on exposure to a physical factor. In the latter case, the urticaria is classified as a physical urticari...

Mepolizumab in Episodic Angioedema With Eosinophilia
https://clinicaltrials.gov/ct2/show/NCT04128371

Jun 24th, 2022 - Episodic angioedema with eosinophilia (EAE), also known as Gleich s Syndrome,is a rare disorder characterized by recurrent episodes of urticaria, fever, angioedema, weight gain and dramatic eosinophilia that occur at 3- to 6-week intervals and res...

Study of Factors Regulating Mast Cell Proliferation
https://clinicaltrials.gov/ct2/show/NCT00044122

Jun 24th, 2022 - This protocol is designed to examine those growth potentiating and inhibiting factors which regulate mast cell number and survival in patients with mastocytosis, and to explore the molecular basis of the disease process in hopes of improving thera...

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine
https://clinicaltrials.gov/ct2/show/NCT05107115

Jun 24th, 2022 - The first phase of this study will be a parallel, 12-week treatment, Phase 2, double-blind, 4 arm study to assess the safety and effectiveness of 3 oral doses of SAR444671 (rilzabrutinib), i.e. dose A, B and C, compared with placebo for decreasing...

see more →

News  382 results

Atopic dermatitis: Options abound, and more are coming
https://www.mdedge.com/dermatology/article/255353/atopic-dermatitis/atopic-dermatitis-options-abound-and-more-are-coming
Kathleen Doheny

Jun 10th, 2022 - For dermatologists and others treating patients with atopic dermatitis (AD), it is “an incredible time,” Lawrence F. Eichenfield, MD, said at MedscapeLive’s Women’s & Pediatric Dermatology Seminar.

Is benzophenone safe in skin care? Part 1: Risks to humans
https://www.mdedge.com/dermatology/article/254723/aesthetic-dermatology/benzophenone-safe-skin-care-part-1-risks-humans
Leslie S. Baumann, MD

May 18th, 2022 - Benzophenones are a family of compounds that include dixoxybenzone, sulisobenzone, and benzophenone-3, or oxybenzone. These benzophenones are found in various skin care and personal care products, including body washes, exfoliants, fragrances, liq.

Activity Score Helps Cold Urticaria Patients Monitor Their Signs, Symptoms, and Encounters With Cold
https://www.medscape.com/viewarticle/973382

May 4th, 2022 - A newly developed rating scale called the Cold Urticaria Activity Score (ColdUAS) can help patients with cold urticaria (ColdU) monitor their signs, symptoms, exposure to cold, and avoidance of cold by answering four simple questions, according to...

A case of cold, purple toes
https://www.mdedge.com/familymedicine/article/253770/dermatology/case-cold-purple-toes
MDedge Family Medicine;

Apr 14th, 2022 - A punch-biopsy was performed on the left second toe where the erythema was the most intense. It demonstrated classic findings for pernio: superficial and deep perivascular lymphocytic inflammation and papillary dermal edema on the acral surface.

Treat or Refer? New Primary Care Flow Diagrams for Allergy Patients
https://www.medscape.com/viewarticle/971747

Apr 7th, 2022 - A recently published set of treatment flow diagrams uses simplified diagnosis and management pathways to help primary care providers (PCPs) in Europe, the United States, and elsewhere treat patients with allergies. Most patients with allergy probl...

see more →

Patient Education  11 results see all →